BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23189967)

  • 1. Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.
    Rotili D; Tarantino D; Nebbioso A; Paolini C; Huidobro C; Lara E; Mellini P; Lenoci A; Pezzi R; Botta G; Lahtela-Kakkonen M; Poso A; Steinkühler C; Gallinari P; De Maria R; Fraga M; Esteller M; Altucci L; Mai A
    J Med Chem; 2012 Dec; 55(24):10937-47. PubMed ID: 23189967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
    Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
    Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.
    Rotili D; Tarantino D; Carafa V; Paolini C; Schemies J; Jung M; Botta G; Di Maro S; Novellino E; Steinkühler C; De Maria R; Gallinari P; Altucci L; Mai A
    J Med Chem; 2012 Sep; 55(18):8193-7. PubMed ID: 22931526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
    Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
    Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
    Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
    Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.
    Rotili D; Carafa V; Tarantino D; Botta G; Nebbioso A; Altucci L; Mai A
    Bioorg Med Chem; 2011 Jun; 19(12):3659-68. PubMed ID: 21306905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells.
    Kalle AM; Mallika A; Badiger J; Alinakhi ; Talukdar P; Sachchidanand
    Biochem Biophys Res Commun; 2010 Oct; 401(1):13-9. PubMed ID: 20813094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
    Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.
    Jin Y; Cao Q; Chen C; Du X; Jin B; Pan J
    BMC Cancer; 2015 Apr; 15():226. PubMed ID: 25884180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antiproliferative activity of hydroxynaphthyl-beta-D-xylosides.
    Jacobsson M; Ellervik U; Belting M; Mani K
    J Med Chem; 2006 Mar; 49(6):1932-8. PubMed ID: 16539380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
    Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
    J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
    Neugebauer RC; Uchiechowska U; Meier R; Hruby H; Valkov V; Verdin E; Sippl W; Jung M
    J Med Chem; 2008 Mar; 51(5):1203-13. PubMed ID: 18269226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity.
    Mai A; Valente S; Rotili D; Massa S; Botta G; Brosch G; Miceli M; Nebbioso A; Altucci L
    Int J Biochem Cell Biol; 2007; 39(7-8):1510-22. PubMed ID: 17482499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects.
    Choi G; Lee J; Ji JY; Woo J; Kang NS; Cho SY; Kim HR; Ha JD; Han SY
    Int J Oncol; 2013 Oct; 43(4):1205-11. PubMed ID: 23900402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
    Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G
    Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carprofen analogues as sirtuin inhibitors: enzyme and cellular studies.
    Mellini P; Carafa V; Di Rienzo B; Rotili D; De Vita D; Cirilli R; Gallinella B; Provvisiero DP; Di Maro S; Novellino E; Altucci L; Mai A
    ChemMedChem; 2012 Nov; 7(11):1905-8. PubMed ID: 24155041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53.
    Ghosh A; Sengupta A; Seerapu GPK; Nakhi A; Shivaji Ramarao EVV; Bung N; Bulusu G; Pal M; Haldar D
    Biochem Biophys Res Commun; 2017 Jul; 488(3):562-569. PubMed ID: 28526414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 1-(omega-aminoalkyl)naphthoindolediones with antiproliferative properties.
    Shchekotikhin AE; Buyanov VN; Preobrazhenskaya MN
    Bioorg Med Chem; 2004 Jul; 12(14):3923-30. PubMed ID: 15210159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and cell death mechanisms induced by a novel bisnaphthalimidopropyl derivative against the NCI-H460 non-small lung cancer cell line.
    Lima RT; Barron GA; Grabowska JA; Bermano G; Kaur S; Roy N; Vasconcelos MH; Lin PK
    Anticancer Agents Med Chem; 2013 Mar; 13(3):414-21. PubMed ID: 23092269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives.
    Zou HB; Dong SY; Zhou CX; Hu LH; Wu YH; Li HB; Gong JX; Sun LL; Wu XM; Bai H; Fan BT; Hao XJ; Stöckigt J; Zhao Y
    Bioorg Med Chem; 2006 Mar; 14(6):2060-71. PubMed ID: 16303311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.